Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Liver Dis. 1997 Nov;1(3):615-30.

Treatment of acute and chronic hepatitis C.

Author information

  • 1Section of Hepatobiliary Diseases, Department of Medicine, University of Florida College of Medicine, Gainesville, FL 32610-0214, USA.

Abstract

Interferon is currently the only available treatment for chronic hepatitis C but is effective in only about 40% of patients. Most of these responding patients relapse after short courses, so that sustained long-term viral-negative responses are uncommon (10% to 20%). However, longer treatment courses have significantly reduced relapse, thereby increasing sustained response rates. Furthermore, the combination of ribavirin with interferon shows promise for reducing relapse even further. The challenge for the future is to develop antiviral agents that will be effective in the large proportion of patients who do not respond to interferon.

PMID:
15560062
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk